Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 694 of 5804
-
Could a quick MRI catch more breast cancers in black women?
Diagnosis Ongoing500 patients will be prospectively recruited to undergo a fast breast MRI examination. The women will be recruited for the study will meet the following criteria: 1. African American 2. negative DBT examination 11 months prior to recruitment 3. Heterogeneously and Extremely breas…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Could a lower chemo dose make transplants safer for older patients?
Disease control Recruiting nowBackground: Certain blood cancers can be treated with blood or bone marrow transplants. Sometimes the donor cells attack the recipient's body, called graft-versus-host disease (GVHD). The chemotherapy drug cyclophosphamide helps reduce the risk and severity of GVHD. Researchers …
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New pill could outshine chemo for common blood cancer
Disease control OngoingThe purpose of this study is to compare the efficacy and safety of pirtobrutinib (LOXO-305; Arm A) compared to BR (Arm B) in patients with CLL/SLL who have not been treated. Participation could last up to five years.
Phase: PHASE3 • Sponsor: Loxo Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Simple drug during surgery may stop chronic pain after breast cancer
Prevention Recruiting nowPhase III, international multicentre, parallel group, blinded, 1:1 randomized controlled trial to determine the effect of an intraoperative intravenous lidocaine infusion on reducing the development of persistent pain 3-months after breast cancer surgery.
Phase: PHASE3 • Sponsor: University Health Network, Toronto • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
TB vaccine booster shows promise in speeding up recovery
Disease control CompletedProspective, randomized, double-blind, multicentre, placebo-controlled clinical phase IIb trial to evaluate efficacy of RUTI® vaccine in DS- (Drug-Sensitive) and MDR-TB (Multidrug-resistant) patients favourably responding to standard MDR-TB treatment. Time point of vaccination st…
Phase: PHASE2 • Sponsor: Archivel Farma S.L. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a drug combo replace stem cell transplants for some myeloma patients?
Disease control Recruiting nowThis is a phase II interventional study evaluating the use of minimal residual disease by next generation sequencing to defer autologous hematopoietic stem cell transplantation (AHCT) in patients with newly diagnosed multiple myeloma (cohort A) and amyloidosis (cohort B).
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New combo shows promise for rare thymic cancer
Disease control CompletedThis is a multicentric, open-label, single arm phase II study to evaluate the efficacy and safety of the combination of pembrolizumab and lenvatinib in pre-treated thymic carcinoma patients who have progressed after at least one line of platinum-based chemotherapy for advanced di…
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New rapid test could slash TB diagnosis time in High-Burden regions
Diagnosis CompletedThe performance of a new triage test for active tuberculosis (TB), SeroSelectTB, will be qualified in multi-centre randomised controlled trials at health-posts in South Africa, Tanzania and Ethiopia. Cost effectiveness evaluations will be conducted to support a value proposition …
Phase: NA • Sponsor: Norwegian Institute of Public Health • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Hope for kidney patients: new pill may slow disease without diabetes
Disease control CompletedResearchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial treatment, finerenone, is being developed to help people who have long lasting kidney disease, also known as chronic kidney disease (CKD). It works …
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope for seniors with aggressive blood cancer: targeted combo shows promise
Disease control OngoingThe purpose of this study is to test the effectiveness and safety of polatuzumab vedotin in combination with R-miniCHP in patients 75 years and older with DLBCL.
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New hope for blood cancer patients: triple therapy aims to keep disease in check longer
Disease control OngoingThe purpose of this study is to compare the efficacy and safety of fixed duration pirtobruitinib (LOXO-305) with VR (Arm A) compared to VR alone (Arm B) in patients with CLL/SLL who have been previously treated with at least one prior line of therapy. Participation could last up …
Phase: PHASE3 • Sponsor: Loxo Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug cocktail targets tough cancers in early trial
Disease control CompletedBackground: Small cell lung cancer and PARP inhibitor resistant tumors are aggressive cancers. Current treatments for people with these tumors yield little benefit. Researchers want to see if a combination of drugs can help. Objective: To find a safe combination of sacituzumab…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New hope for kids with tough cancers: personalized cell therapy trial launches
Disease control Recruiting nowA Phase I open-label, multicenter study, to evaluate the safety, feasibility, and maximum tolerated dose (MTD) of treating children with newly diagnosed DIPG or recurrent neuroblastoma with molecular targeted therapy in combination with adoptive cell therapy (Total tumor mRNA-pul…
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could donor immune cells beat COVID-19? new trial begins.
Disease control Recruiting nowThe 2019 Severe Acute Respiratory Syndrome (SARS) is a global pandemic secondary to a novel coronavirus - SARS-CoV-2. The reported case-fatality ratio for SARS-CoV-2 in the United States is 1.8% with a current death toll of \>300,000 and climbing.4 There is no accepted standard o…
Phase: PHASE1, PHASE2 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New eye drop aims to tame uveitis inflammation
Disease control CompletedThe primary objective of this study is to evaluate the efficacy and safety of TRS01 eye drops compared to active comparator in subjects with active non-infectious anterior uveitis with or without uveitic glaucoma
Phase: PHASE3 • Sponsor: Tarsier Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Brain scan guided magnetic pulses aim to beat depression
Symptom relief Recruiting nowRepetitive transcranial magnetic stimulation (rTMS) is a treatment for depression. The investigators are continuing to learn how to optimize outcomes from rTMS treatment. The purpose of this research project is to use brain network connectivity patterns as measured by resting sta…
Phase: PHASE3 • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New study tests best ways to get opioid treatment to those who need it
Disease control CompletedThis study will examine the effectiveness of opioid use disorder (OUD) treatment linkage strategies for patients identified at sexual health clinics and through community outreach and referrals. This 3-arm RCT will compare Usual Care vs. Patient Navigation vs. Patient Navigation …
Phase: PHASE2, PHASE3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could young Athletes' plasma slow Alzheimer's? new study tests the idea
Disease control OngoingIntroduction Given that exercise training reduces the risk of developing Alzheimer's disease (AD), induces changes in the blood composition and has widespread systemic benefits, it is reasonable to hypothesize that exercised plasma may have rejuvenative properties. The main objec…
Phase: PHASE2 • Sponsor: Norwegian University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for pancreatic cancer: drug combo shows promise in early trial
Disease control OngoingPhase 1b/2 study to assess the safety and efficacy of mitazalimab in combination with chemotherapy in patients with metastatic pancreatic ductal adenocarcinoma.
Phase: PHASE1, PHASE2 • Sponsor: Alligator Bioscience AB • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug cocktail aims to wipe out breast cancer before surgery
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of Sintilimab plus anlotinib combined with chemotherapy as neoadjuvant therapy in participants who have triple negative breast cancer (TNBC). After a screening phase of approximately 28 days, each participant will r…
Phase: PHASE2 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC